Works matching IS 09024441 AND DT 2022 AND VI 108 AND IP 3


Results: 11
    1

    Time‐dependent analysis of adoptive immunotherapy following sequential FLAMSA‐reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high‐risk myeloid neoplasia.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 3, p. 244, doi. 10.1111/ejh.13732
    By:
    • Weller, Jan Frederic;
    • Mezger, Markus;
    • Seifert, Leon Louis;
    • Vogel, Wichard;
    • Schneidawind, Dominik;
    • Faul, Christoph;
    • Bethge, Wolfgang;
    • Lengerke, Claudia;
    • Christopeit, Maximilian
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Issue Information.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 3, p. 167, doi. 10.1111/ejh.13653
    Publication type:
    Article
    11

    Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 3, p. 178, doi. 10.1111/ejh.13723
    By:
    • Morabito, Fortunato;
    • Zamagni, Elena;
    • Conticello, Concetta;
    • Pavone, Vincenzo;
    • Palmieri, Salvatore;
    • Bringhen, Sara;
    • Galli, Monica;
    • Mangiacavalli, Silvia;
    • Derudas, Daniele;
    • Rossi, Elena;
    • Ria, Roberto;
    • Catalano, Lucio;
    • Tacchetti, Paola;
    • Mele, Giuseppe;
    • Donatella Vincelli, Iolanda;
    • Antonia Martino, Enrica;
    • Vigna, Ernesto;
    • Botta, Cirino;
    • Bruzzese, Antonella;
    • Mele, Anna
    Publication type:
    Article